121 related articles for article (PubMed ID: 2209636)
1. Treatment of advanced or recurrent adenocarcinoma of the endometrium with doxorubicin and cyclophosphamide.
Campora E; Vidali A; Mammoliti S; Ragni N; Conte PF
Eur J Gynaecol Oncol; 1990; 11(3):181-3. PubMed ID: 2209636
[TBL] [Abstract][Full Text] [Related]
2. Use of cisplatin, doxorubicin, and cyclophosphamide to treat advanced and recurrent adenocarcinoma of the endometrium.
Hancock KC; Freedman RS; Edwards CL; Rutledge FN
Cancer Treat Rep; 1986 Jun; 70(6):789-91. PubMed ID: 3731140
[TBL] [Abstract][Full Text] [Related]
3. Prospective treatment of advanced or recurrent endometrial carcinoma with cisplatin, doxorubicin, and cyclophosphamide.
Burke TW; Stringer CA; Morris M; Freedman RS; Gershenson DM; Kavanagh JJ; Edwards CL
Gynecol Oncol; 1991 Mar; 40(3):264-7. PubMed ID: 2013451
[TBL] [Abstract][Full Text] [Related]
4. Treatment of advanced or recurrent endometrial adenocarcinoma with cyclophosphamide, doxorubicin, cis-Platinum, and megestrol acetate.
Lovecchio JL; Averette HE; Lichtinger M; Townsend PA; Girtanner RW; Fenton AN
Obstet Gynecol; 1984 Apr; 63(4):557-60. PubMed ID: 6538327
[TBL] [Abstract][Full Text] [Related]
5. Treatment of recurrent and metastatic endometrial cancer with cisplatin, doxorubicin, cyclophosphamide, and megestrol acetate.
Hoffman MS; Roberts WS; Cavanagh D; Praphat H; Solomon P; Lyman GH
Gynecol Oncol; 1989 Oct; 35(1):75-7. PubMed ID: 2477317
[TBL] [Abstract][Full Text] [Related]
6. Treatment of advanced and recurrent endometrial carcinoma: correlation of patient response to hormonal and cytotoxic chemotherapy and the response predicted by the subrenal capsule chemosensitivity assay.
Stratton JA; Mannel RS; Rettenmaier MA; Berman ML; DiSaia PJ
Gynecol Oncol; 1989 Jan; 32(1):55-9. PubMed ID: 2535831
[TBL] [Abstract][Full Text] [Related]
7. [Combination chemotherapy using cyclophosphamide, adriamycin, and cisplatin in recurrent or advanced endometrial cancer--a preliminary report].
Baba S; Kashimura M; Shinohara M; Kusano S; Sasayama T; Hamasaki K
Gan No Rinsho; 1989 Feb; 35(3):371-7. PubMed ID: 2926985
[TBL] [Abstract][Full Text] [Related]
8. A randomized comparison of doxorubicin alone versus doxorubicin plus cyclophosphamide in the management of advanced or recurrent endometrial carcinoma: A Gynecologic Oncology Group study.
Thigpen JT; Blessing JA; DiSaia PJ; Yordan E; Carson LF; Evers C
J Clin Oncol; 1994 Jul; 12(7):1408-14. PubMed ID: 8021731
[TBL] [Abstract][Full Text] [Related]
9. Cisplatin-based chemotherapy regimen (DECAV) for uterine sarcomas.
Pautier P; Genestie C; Fizazi K; Morice P; Mottet C; Haie-Meder C; Le Cesne A; Lhommé C
Int J Gynecol Cancer; 2002; 12(6):749-54. PubMed ID: 12445254
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of doxorubicin/docetaxel/cyclophosphamide for locally advanced and metastatic breast cancer: results from NSABP trial BP-58.
Smith RE; Anderson SJ; Brown A; Scholnik AP; Desai AM; Kardinal CG; Lembersky BC; Mamounas EP
Clin Breast Cancer; 2002 Dec; 3(5):333-40. PubMed ID: 12533263
[TBL] [Abstract][Full Text] [Related]
11. Treatment of fallopian tube carcinoma with cisplatin, doxorubicin, and cyclophosphamide.
Morris M; Gershenson DM; Burke TW; Kavanagh JJ; Silva EG; Wharton JT
Obstet Gynecol; 1990 Dec; 76(6):1020-4. PubMed ID: 2234710
[TBL] [Abstract][Full Text] [Related]
12. [A case of recurrent endometrial cancer (clear cell adenocarcinoma) remarkably responsive to combination chemotherapy containing cisplatin].
Kitayama S; Iwahashi M; Iwahashi M; Yamoto M; Nakano R
Gan To Kagaku Ryoho; 1989 May; 16(5):2099-101. PubMed ID: 2730095
[TBL] [Abstract][Full Text] [Related]
13. Phase II trial of cisplatin, adriamycin, and etoposide for metastatic endometrial adenocarcinoma.
Piver MS; Fanning J; Baker TR
Am J Clin Oncol; 1991 Jun; 14(3):200-2. PubMed ID: 2031506
[TBL] [Abstract][Full Text] [Related]
14. High-dose doxorubicin, etoposide, and cyclophosphamide with stem cell reinfusion in patients with metastatic or high-risk primary breast cancer. City of Hope Bone Marrow Oncology Team.
Somlo G; Doroshow JH; Forman SJ; Leong LA; Margolin KA; Morgan RJ; Raschko JW; Akman SA; Ahn C; Nagasawa S
Cancer; 1994 Mar; 73(6):1678-85. PubMed ID: 7512436
[TBL] [Abstract][Full Text] [Related]
15. Filgrastim support during combination chemotherapy using cisplatin, doxorubicin, and cyclophosphamide to treat advanced or recurrent endometrial cancer: a clinical study and literature review.
Hall DJ; Martin DA; Kincaid K
Eur J Gynaecol Oncol; 2003; 24(6):481-9. PubMed ID: 14658586
[TBL] [Abstract][Full Text] [Related]
16. Treatment of advanced endometrial carcinoma with cisplatin, cyclophosphamide and doxorubicin.
Deppe G; Lin Liu T
Acta Obstet Gynecol Scand; 1985; 64(1):83-4. PubMed ID: 4038840
[TBL] [Abstract][Full Text] [Related]
17. Postoperative adjuvant chemotherapy with cisplatin, cyclophosphamide, and anthracycline (doxorubicin, epirubicin, pirarubicin) for endometrial cancer.
Yahata H; Hirakawa T; Fujita T; Ariyoshi K; Sonoda K; Amada S; Kobayashi H; Nakano H
Int J Clin Oncol; 2004 Aug; 9(4):317-21. PubMed ID: 15375709
[TBL] [Abstract][Full Text] [Related]
18. Treatment of advanced and recurrent endometrial cancer with cisplatin, doxorubicin, and cyclophosphamide.
Dunton CJ; Pfeifer SM; Braitman LE; Morgan MA; Carlson JA; Mikuta JJ
Gynecol Oncol; 1991 May; 41(2):113-6. PubMed ID: 2050302
[TBL] [Abstract][Full Text] [Related]
19. Phase II trial of doxorubicin, 5-fluorouracil, etoposide, and cisplatin in advanced or recurrent endometrial carcinoma.
Pierga JY; Diéras V; Beuzeboc P; Dorval T; Palangié T; Jouve M; Scholl SM; Garcia-Giralt E; Pouillart P
Gynecol Oncol; 1997 Aug; 66(2):246-9. PubMed ID: 9264570
[TBL] [Abstract][Full Text] [Related]
20. Treatment of recurrent and metastatic adenocarcinoma of the endometrium with cisplatin, doxorubicin, cyclophosphamide, and medroxyprogesterone acetate.
Fung MF; Krepart GV; Lotocki RJ; Heywood M
Obstet Gynecol; 1991 Dec; 78(6):1033-8. PubMed ID: 1945203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
